Diabetes Intervention for Agenda Trial: study of the efficacy of a patient-orientated agenda (produced by the PACE-D tool) for use in a diabetes clinical consultatio

Not Applicable

Completed

• Conditions: Topic: Diabetes Research Network; Subtopic: Both; Disease: Diabetic Control; Nutritional, Metabolic, Endocrine; Diabetes mellitus

• Registration Number: ISRCTN75070242
• Lead Sponsor: Royal Devon and Exeter NHS Foundation Trust (UK)

Brief Summary

2013 results in http://www.ncbi.nlm.nih.gov/pubmed/23903815 2019 qualitative results in https://pubmed.ncbi.nlm.nih.gov/31203240/ (added 18/06/2020)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-06-12
• Study Completion: 2015-05-22
• Last Update Posted: 29 June 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

1. People with type 1 or type 2 diabetes mellitus
2. Due to attend for hospital outpatient appointment
3. Aged 18 and over
4. Basic written and spoken English (to complete outcome measures)

Exclusion Criteria

1. People with gestational diabetes
2. People receiving insulin pump therapy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood glucose is measured by measuring glycosylated haemoglobin (HbA1c) at baseline and 6 months.